613 related articles for article (PubMed ID: 15350939)
1. Neoadjuvant therapy for resectable pancreatic cancer.
Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant therapy for pancreatic cancer: the Duke experience.
White RR; Tyler DS
Surg Oncol Clin N Am; 2004 Oct; 13(4):675-84, ix-x. PubMed ID: 15350941
[TBL] [Abstract][Full Text] [Related]
3. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
4. The Virginia Mason approach to localized pancreatic cancer.
Picozzi VJ; Traverso LW
Surg Oncol Clin N Am; 2004 Oct; 13(4):663-74, ix. PubMed ID: 15350940
[TBL] [Abstract][Full Text] [Related]
5. Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure.
Zimmermann FB; Schuhmacher C; Lersch C; Bernhardt B; Pickel P; Siewert JR; Molls M; Jeremic B
Hepatogastroenterology; 2004; 51(60):1842-6. PubMed ID: 15532839
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy for pancreatic cancer: current status and future directions.
Xiong HQ; Abbruzzese JL
Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
[TBL] [Abstract][Full Text] [Related]
7. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
[TBL] [Abstract][Full Text] [Related]
8. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
Ghaneh P; Neoptolemos JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy following resection for pancreatic adenocarcinoma.
Brennan MF
Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
Zhu AX; Clark JW; Willett CG
Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
Stessin AM; Meyer JE; Sherr DL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?
Pisters PW; Evans DB
Ann Surg; 2008 Aug; 248(2):152-3. PubMed ID: 18650622
[No Abstract] [Full Text] [Related]
13. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.
Greer SE; Pipas JM; Sutton JE; Zaki BI; Tsapakos M; Colacchio TA; Gibson JJ; Wiener DC; Ripple GH; Barth RJ
J Am Coll Surg; 2008 Mar; 206(3):451-7. PubMed ID: 18308215
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
15. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.
Turrini O; Ychou M; Moureau-Zabotto L; Rouanet P; Giovannini M; Moutardier V; Azria D; Delpero JR; Viret F
Eur J Surg Oncol; 2010 Oct; 36(10):987-92. PubMed ID: 20828979
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
Meszoely IM; Wang H; Hoffman JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):685-96, x. PubMed ID: 15350942
[TBL] [Abstract][Full Text] [Related]
18. The case for routine use of adjuvant therapy in pancreatic cancer.
Kennedy EP; Yeo CJ
J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
[TBL] [Abstract][Full Text] [Related]
19. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
[TBL] [Abstract][Full Text] [Related]
20. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
